<DOC>
	<DOCNO>NCT02534545</DOCNO>
	<brief_summary>The primary objective study determine whether remote limb ischemic conditioning ( RLIC ) compare sham RLIC ( placebo ) treatment reduce 12-month risk recurrent IS patient recent TIA IS cause stenosis major intracranial artery . After screen period , eligible patient randomly allocate 2 group . In addition , participant receive usual clinical therapy .</brief_summary>
	<brief_title>Remote Ischemic Conditioning Avoiding Recurrence Symptomatic Intracranial Atherosclerotic Stenosis ( sICAS )</brief_title>
	<detailed_description>In study , Patients RLIC group treat Renqiao Remote Ischemic Conditioning Device ( Doctormate® ) ( 200mmHg ) daily 12 month ; patient sham RLIC group treat Renqiao Remote Ischemic Conditioning Device ( Doctormate® ) ( 60mmHg ) daily 12 month . In study , RLIC treatment comprise 5 cycle bilateral upper limb ischemia reperfusion , induce 2 cuff place around upper arm respectively inflate 200mmHg 5 minute follow 5 minute reperfusion cuff deflation . Sham RLIC treatment conduct use procedure minimal inflation pressure 60mmHg , result upper limb ischemia . In addition , participant receive usual drug therapy accord local medical practice .</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Intracranial Arteriosclerosis</mesh_term>
	<criteria>1 . Male female age 40 80 year old . 2 . Patients ischemic stroke TIA prior randomization . Patient ischemic stroke within 30 day mRS score≤4 baseline . Patient TIA within 15 day Oxfordshire Community Stroke Project basis age , blood pressure ( BP ) , clinical feature , duration TIA symptom ( ABCD2 ) score≥4 baseline . 3 . The entry event attribute symptomatic atherosclerotic stenosis ( 5099 % ) intracranial qualify artery ( carotid artery , middle cerebral artery ( M1 ) , vertebral artery , basilar artery ) document magnetic resonance angiography ( MRA ) compute tomographic angiography ( CTA ) . 4 . Informed consent obtain . 1 . Thrombolytic therapy within 24 hour prior enrollment . 2 . Progressive neurological sign within 24 hour prior enrollment . 3 . Cerebral venous thrombosis/stenosis . 4 . Intracranial arterial stenosis due arterial dissection , Moya Moya disease ; know vasculitic disease ; herpes zoster , varicella zoster viral vasculopathy ; neurosyphilis ; intracranial infection ; intracranial stenosis associate cerebrospinal fluid ( CSF ) pleocytosis ; radiation induce vasculopathy ; fibromuscular dysplasia ; sickle cell disease ; neurofibromatosis ; benign angiopathy central nervous system ; postpartum angiopathy ; suspect vasospastic process , suspect recanalized embolus . 5 . Any following unequivocal cardiac source embolism : rheumatic mitral aortic stenosis , prosthetic heart valve , atrial fibrillation , atrial flutter , sick sinus syndrome , leave atrial myxoma , patent foramen ovale , leave ventricular mural thrombus valvular vegetation , congestive heart failure , bacterial endocarditis , cardiovascular condition interfere participation . 6 . Uncontrolled severe hypertension [ sit systolic blood pressure ( SBP ) &gt; 180 mmHg and/or sit diastolic blood pressure ( DBP ) &gt; 110 mmHg medication ] . 7 . Patients abnormal laboratory parameter : aspartate transaminase ( AST ) and/or alanine transaminase ( ALT ) &gt; 3×upper limit normal range ; creatinine clearance &lt; 0.6 ml/s and/or serum creatinine &gt; 265 μmol/l ( &gt; 3.0 mg/dl ) ; platelet &lt; 100×109/L . 8 . Any intracranial hemorrhage ( parenchymal , subarachnoid , subdural , epidural ) within 90 day prior enrollment . 9 . Intracranial neoplasm , cerebral aneurysm arteriovenous malformation . 10 . Known retinal hemorrhage visceral bleeding within 30 day prior enrollment . 11 . Severe hemostatic disorder severe coagulation dysfunction . 12 . Subclavian arterial stenosis≥50 % subclavian steal syndrome . 13 . Extracranial stenosis ≥50 % . 14 . Previous treatment target lesion stent , angioplasty , mechanical device , plan perform one procedure within 12 month enrollment . 15 . Major surgery ( include open femoral , aortic , carotid surgery , cardiac ) within previous 30 day schedule 12 month enrollment . 16 . Contraindication remote ischemic conditioning : severe soft tissue injury , fracture , peripheral vascular disease upper limb . 17 . Life expectancy &lt; 3 year . 18 . Pregnant breastfeed woman . 19 . Unwilling follow poor compliance treatment . 20 . Patients enrol enrolled clinical trial within 3 month prior clinical trial . 21 . Patients unsuitable enrollment clinical trial accord investigator decision making .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Intracranial atherosclerotic stenosis</keyword>
	<keyword>ischemia</keyword>
	<keyword>remote ischemic conditioning</keyword>
	<keyword>stroke</keyword>
</DOC>